New line of attack against advanced prostate cancer in a study led by a Catalan scientist

<p>Xavier Salvatella (Photo: Battista/MinocriIRB Barcelona)</p>

Xavier Salvatella (Photo: Battista/MinocriIRB Barcelona)

The Catalan Media Corporation, La Razón and have highlighted a study conducted by Xavier Salvatella, ICREA researcher at IRB Barcelona, and published in the journal Structure early in December. In this work, he proposes various ways to tackle prostate cancer and focuses on the androgen receptor protein, which tumour cells need to survive and proliferate. 

Link to CCMA

Link to La Razón

Link to